Skip to main content

Table 2 Clinical scores

From: Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

#

RUE (75)

LUE (75)

RLE (45)

LLE (45)

UE (150)

LE (90)

all E. (240)

fasc. (0–42)

atr. (0–30)

bulb. (0–14)

Bab. (0–2)

spast. (0–32)

refl. (0–13)

ALSFRS-R PR/mth(6)

ALSFRS-R PR/mth(t)

1

68

69

41

41

137

82

219

5

7

2

0

0

0

0.5

0.2

2

75

64

31

27

139

58

197

7

4

0

0

0

0

1.8

0.8

3

64

62

45

45

126

90

216

15

8

0

2

0

12

1.2

0.4

4

75

73

45

42

148

87

235

10

2

2

2

4

4

0.7

0.4

5

72

75

26

16

147

42

189

15

8

0

1

0

6

0.7

0.4

6

67

59

14

13

126

27

153

4

6

0

0

0

6

1.2

0.5

7

74

75

26

23

149

49

198

12

2

0

0

0

0

0.2

0.1

8

70

71

45

45

141

90

231

1

2

4

2

0

12

1.0

0.5

9

60

60

36

39

120

75

195

17

6

0

0

0

0

1.0

0.3

10

63

73

45

45

136

90

226

6

5

4

0

0

12

0.7

0.4

11

54

55

45

45

109

90

199

4

6

0

2

0

0

0.3

0.4

12

58

43

38

38

101

76

177

11

10

3

2

0

6

0.5

0.6

13

58

57

45

45

115

90

205

8

7

2

2

0

5

1.5

0.5

14

70

71

22

37

141

59

200

7

6

0

2

2

12

1.7

0.4

15

75

75

45

45

150

90

240

1

0

3

0

0

11

0.2

0.3

16

61

71

44

44

132

88

220

9

8

0

1

0

0

0.0

0.0

17

69

71

40

41

140

81

221

6

4

3

2

4

6

1.0

0.3

mean

66.6

66.1

37.2

37.1

132.8

74.4

207.1

8.1

5.4

1.4

1.1

0.6

5.4

0.82

0.38

± S.D.

6.7

9.0

9.9

10.6

14.6

19.9

22.3

4.7

2.7

1.6

1.0

1.4

4.9

0.54

0.20

Δ norm (%)

-11%

-12%

-17%

-18%

-11%

-17%

-14%

19%

18%

10%

53%

2%

42%

  
  1. MRC sum scores were used to describe muscle strength for right upper (RUE), left upper (LUE), right lower (RLE), left lower (LLE), upper (UE) and lower (LE) and all extremities (all E., see methods); disease related strength reduction is displayed as percent in the lower row. Sum scores of fasciculations, atrophy, bulbar signs, Babinski sign, spasticity and reflexes are represented as pathologic increase; the lower row values show percent of maximal pathologic scores. ALSFRS progression rates per month are calculated for the 6 months prior to MRI [PR/mth(6)] and the total disease duration [PR/mth(t)].